Tormentic acid
(Synonyms: 2Α,19Α-二羟基熊果酸) 目录号 : GC39085A triterpene with diverse biological activities
Cas No.:13850-16-3
Sample solution is provided at 25 µL, 10mM.
Tormentic acid is a triterpene that has been found in P. frutescens and has diverse biological activities, including anti-inflammatory, anticancer, antioxidative, and antidiabetic properties.1,2,3 It reduces hydrogen peroxide-induced increases in inducible nitric oxide synthase (iNOS) and NADPH oxidase (NOX1), as well as the production of TNF-α, IL-6, and IL-1β in rat vascular smooth muscle cells (RVSMCs) when used at concentrations of 12.5, 25, and 50 ?M.2 Tormentic acid (25 and 50 ?M) decreases hydrogen peroxide-induced generation of reactive oxygen species (ROS) in RVSMCs. It reduces ear edema induced by phorbol 12-myristate 13-acetate in mice (ID50 = 0.03 mg/ear).1 Topical application of tormentic acid (1.7 nmol) reduces the number of papillomas formed per mouse in a DMBA-TPA two-stage model of mouse skin carcinogenesis. It also reduces increases in blood glucose, insulin, and leptin levels, as well as hepatic triglyceride levels, in mice fed a high-fat diet in a model of diabetes and hyperlipidemia when administered at doses of 60 and 120 mg/kg per day.3
1.Banno, N., Akihisa, T., Tokuda, H., et al.Triterpene acids from the leaves of Perilla frutescens and their anti-inflammatory and antitumor-promoting effectsBiosci. Biotechnol. Biochem.68(1)85-90(2004) 2.Wang, Y.-L., Sun, G.-Y., Zhang, Y., et al.Tormentic acid inhibits H2O2-induced oxidative stress and inflammation in rat vascular smooth muscle cells via inhibition of the NF-κB signaling pathwayMol. Med. Rep.14(4)3559-3564(2016) 3.Wu, J.-B., Kuo, Y.-H., Lin, C.-H., et al.Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylationJ. Agric. Food Chem.62(44)10717-10726(2014)
Cas No. | 13850-16-3 | SDF | |
别名 | 2Α,19Α-二羟基熊果酸 | ||
Canonical SMILES | OC([C@]12[C@]([C@](O)([C@H](C)CC2)C)([H])C3=CC[C@@]([C@@]4([C@@](C(C)([C@@H](O)[C@H](O)C4)C)([H])CC5)C)([H])[C@]5(C)[C@]3(C)CC1)=O | ||
分子式 | C30H48O5 | 分子量 | 488.7 |
溶解度 | DMSO : 50 mg/mL (102.31 mM; Need ultrasonic) | 储存条件 | 4°C, protect from light |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.0462 mL | 10.2312 mL | 20.4625 mL |
5 mM | 0.4092 mL | 2.0462 mL | 4.0925 mL |
10 mM | 0.2046 mL | 1.0231 mL | 2.0462 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet